EOIB for Pain After Laparoscopic Cholecystectomy
External Oblique Intercostal Block for Postoperative Pain After Laparoscopic Cholecystectomy: A Randomized Controlled Trial
Shiyou Wei
56 participants
Jan 15, 2026
INTERVENTIONAL
Conditions
Summary
This prospective, randomized, controlled, assessor-blinded trial will evaluate whether bilateral ultrasound-guided external oblique intercostal block (EOIB) reduces postoperative opioid consumption and improves pain control after laparoscopic cholecystectomy, compared with no block.
Eligibility
Inclusion Criteria4
- Aged 18-85 years, regardless of gender
- American Society of Anesthesiologists (ASA) physical status classification I-III
- Scheduled for elective laparoscopic cholecystectomy
- Ability to use the intravenous patient-controlled analgesia (IV PCA) system
Exclusion Criteria7
- Hepatic disease (e.g., liver enzyme levels ≥ 2× the upper limit of normal)
- Renal disease (e.g., serum creatinine levels ≥ 2× the upper limit of normal)
- Allergy or known hypersensitivity to local anesthetics
- Females who are pregnant or lactating
- Conversion to open surgery
- Coagulopathy or current use of anticoagulant medications
- Opioid use for more than 2 weeks in the past 6 months
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Bilateral ultrasound-guided external oblique intercostal block performed under sterile conditions after induction of general anesthesia and before surgical incision. Using an in-plane technique, the block is performed at the level of the 6th rib in the 6th-7th intercostal space. A local anesthetic mixture is injected with a total volume of 15 mL per side (prepared by mixing 0.75% ropivacaine with normal saline).
Participants do not receive any regional anesthesia/nerve block (including external oblique intercostal block). All participants receive standard general anesthesia and the same standardized postoperative multimodal analgesia regimen as per protocol, including intravenous patient-controlled analgesia (PCA) with butorphanol.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07332546